Article Details

Pandion selects Just to cut cost of bispecific Ab development

Retrieved on: 2018-10-02 12:52:30

Tags for this article:

Click the tags to see associated articles and topics

Pandion selects Just to cut cost of bispecific Ab development. View article details on hiswai:

Excerpt

<div>Just Biotherapeutics says smart design and optimization of the molecule and the manufacturing process will speed the development of Pandion ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo